Over 1,800 companies report this week. The calendar is dense with US mega-caps.
Monday (today) sees Marriott International and Vertex Pharmaceuticals both dropping results. Marriott's $98bn hotel giant faces scrutiny over travel demand trends. Vertex reports after the close. Its $121bn market cap makes it one of the biggest pharma prints of the summer.
Tuesday brings the biotech heavyweights. Amgen ($208bn) and Gilead Sciences ($162bn) both report. Booking Holdings also steps up. The $149bn travel platform will give a read on summer spending. The Progressive Corporation rounds out Tuesday. The $123bn insurer is closely watched for catastrophe loss trends.
Wednesday is the biggest day. CVS Health ($133bn) reports at 8am. and follow after the close. and also deliver results. In Europe, posts numbers.
Thursday brings Microchip Technology and Becton Dickinson. SoftBank also reports from Japan. No IPOs are confirmed for the week in our data.
With no major new listings on deck, earnings dominates the market's attention entirely.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
